Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Germany Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20032
20043
20052
20063
20071
20081
20091
20107
20113
20121
20132
20144
20154
20164
20178
20185
20193
20202
20214
20224
20241
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated17
Recruiting10
Active, not recruiting7
Unknown status5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Ulm8
European Organisation for Research and Treatment of Cancer - EORTC7
Stichting Hemato-Oncologie voor Volwassenen Nederland5
AbbVie4
Astellas Pharma Global Development, Inc.3
Astex Pharmaceuticals, Inc.3
Daiichi Sankyo3
Celgene2
Fred Hutchinson Cancer Center2
Gilead Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute81
Leukemia16
Myelodysplastic Syndromes10
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Recurrence5
Congenital Abnormalities4
Leukemia, Erythroblastic, Acute4
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Megakaryoblastic, Acute4
Leukemia, Monocytic, Acute4

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.